Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients with Non-Valvular Atrial Fibrillation (Cognitive Decline and Dementia in Patients with Non-ValvularAtrial Fibrillation (CAF) Trial)
T. Jared Bunch, MD*†, Heidi May, PhD*, Michael J. Cutler, DO, PhD*, Scott C. Woller, MD*‡, Victoria Jacobs, NP, PhD*, Scott M. Stevens, MD*‡, John Carlquist, PhD*‡, Kirk U Knowlton, MD*, Joseph B. Muhlestein MD*†, Benjamin A. Steinberg, MD, MHS†, Jeffrey L. Anderson, MD*†
*Intermountain Heart Institute and Department of Medicine, Intermountain Medical Center; Murray, Utah, USA
†Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah, USA
‡Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA
Address for correspondence: T. Jared Bunch, M.D.
University of Utah School of Medicine Division of Cardiology, Department of Internal Medicine 50 N Medical Drive, Salt Lake City, Utah 84132 Phone: 801-585-7676 Fax: 801-581-7735 Email: jared.bunch@hsc.utah.edu
Funding : This was an independent, investigator-initiated study supported by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI).